Abstract Search

ISEF | Projects Database | Finalist Abstract

| Print PDF

Optimizing Bacteriophage-Infused Hybrid-Hydrogel Matrices to Combat Antibiotic-Resistant Infections

Booth Id:
ENBM072

Category:
Biomedical Engineering

Year:
2026

Finalist Names:
Geisendorfer, Issa (School: Quincy Senior High School)

Abstract:
The growing prevalence of antibiotic-resistant bacterial infections has impacted tens of millions of lives by reducing antibiotic effectiveness and worsening infections, which increases healing times and complications. This study evaluates bacteriophage-infused hybrid-hydrogel bandages as an alternative to conventional antibiotics, with a focus on how hydrogel matrix composition influences antimicrobial activity. 210 Mueller-Hinton agar plates were prepared and spread with full lawns of Escherichia coli K-12. Five hydrogel formulations composed of gelatin, agarose, chitosan, and sodium alginate in varying combinations were synthesized and infused with T4r+ bacteriophages before being applied to 1 cm² sections of sterile gauze. Distilled water-treated plates served as the negative control, and neomycin-treated plates were included as a comparative treatment. Each treatment was tested across 30 plates. After incubation (37 °C for 24 hours), zones of inhibition were measured using digital calipers. Statistical analysis was conducted using one-way ANOVA and the Kruskal-Wallis test, followed by post-hoc comparisons. Statistical analysis revealed significant differences among treatments (one-way ANOVA, p < 0.001; Kruskal-Wallis ?² = 54.96, df = 5, p < 0.001). Post-hoc analysis demonstrated that all hybrid-hydrogel-bacteriophage formulations produced significantly greater inhibition than neomycin (p < 0.01), with the GACS formulation consistently outperforming all other treatments. These results show that hydrogel matrix composition significantly influences bacteriophage delivery and efficacy, supporting the potential of optimized bacteriophage-hybrid-hydrogel bandages as alternatives to conventional antibiotics for treating antibiotic-resistant wound infections.

Awards Won: